HealthEquity (HQY) return on equity (ROE)

Return on equity · fiscal 2026
10.2%

HealthEquity (HQY) earned a return on equity of 10.2% in fiscal 2026 (the year ended January 31, 2026). That is 5.6 percentage points higher than the 4.6% of fiscal 2025. Figures as of 18 Nov 2026, 01:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2026
10.2%
Change on fiscal 2025
+5.6 pts
Highest on record
15.5%fiscal 2019
Lowest on record
-2.4%fiscal 2022
Fiscal years on record
122015–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

HealthEquity return on equity (ROE), in more detail

Across the 12 fiscal years on record (2015–2026), the highest was 15.5% in fiscal 2019 and the lowest -2.4% in fiscal 2022. The fiscal 2026 figure is higher than in 82% of the 11 earlier fiscal years on record, whose median is 4.6%.

History · 12 fiscal years

Return on equity by fiscal year

HealthEquity return on equity (ROE), year by year

HealthEquity (HQY) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202610.2% 5.6 pts up
20254.6% 1.8 pts up
20242.7% 4.1 pts up
2023-1.4% 1.0 pts up
2022-2.4% 3.0 pts down
20210.6% 3.2 pts down
20203.8% 11.6 pts down
201915.5% 1.8 pts up
201813.7% 3.6 pts up
201710.1% 1.9 pts up
20168.2% 1.1 pts up
20157.1%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of HealthEquity and comparable companies
CompanyReturn on equityFiscal year
Twist Bioscience TWST-14.7%2026
Protagonist Therapeutics PTGX-21.2%2025
Krystal Biotech KRYS16.8%2025
HealthEquity HQY10.2%2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HQY

HealthEquity, figure by figure

HealthEquity (HQY) overview: price, valuation and scorecardAll health care companies by market value

HealthEquity return on equity (ROE): questions and answers

What is HealthEquity's return on equity?

HealthEquity (HQY) earned a return on equity of 10.2% in fiscal 2026 (the year ended January 31, 2026). That is 5.6 percentage points higher than the 4.6% of fiscal 2025.

Is HealthEquity's return on equity high or low compared with its own history?

The fiscal 2026 figure is higher than in 82% of the 11 earlier fiscal years on record, whose median is 4.6%.

What are the highest and lowest return on equity figures on record for HealthEquity?

Across the 12 fiscal years on record (2015–2026), the highest was 15.5% in fiscal 2019 and the lowest -2.4% in fiscal 2022.

How is HealthEquity's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “HealthEquity (HQY) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/HQY/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.